An Observational Study of Stroke Patients.

Hypertension Clinical Trial

— SPET-72  

Official title:

An Observational Study of Stroke Patients With Focus on Examinations and Therapeutic Improvement the First 72 Hours.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03259737
• Other study ID #: REK2015/358
• Status: Active, not recruiting
• Start date: May 1, 2018
• Est. completion date: December 1, 2022

Study information

• Verified date: December 2020
• Source: Sykehuset Innlandet HF
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The intention is to study presumed changes in daily practice, probably due to New Guidelines concerning stroke patients. The impression is more frequent measurements of blood pressure, serum glucose, troponin and supplementary computer tomography or magnetic resonance imaging.

Description:

There is in general a focus on misuse of health resources. An increasing amount of guidelines is produced to reduce the variation in treatment of patients with the same diagnosis. Many recommendations are weak but seems though to have considerable impact on in hospital care. The issues to be studied are all grounded on weak clinical evidence. A pilot study confirmed the suspicion of very frequent measurements of blood pressure, glucose, troponin and frequent supplementary CT and MRI. The intention is to study these issues in a larger population including an evaluation of utility of the different examinations and evaluations.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 120
• Est. completion date: December 1, 2022
• Est. primary completion date: November 15, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with a diagnosis of stroke according to ICD 10th revision (code I61 I63 and I64)

• Hospitalized between January 1 and December 31, 2015

Exclusion Criteria:

• Previous hospitalization with a diagnosis of stroke in 2015.

• Foreigners and patients from other regions of Norway.

Related Conditions & MeSH terms

• Cerebrovascular Disorders
• Hyperglycemia
• Hypertension
• Quality of Care
• Troponin

Locations

Country	Name	City	State
Norway	Ellen Bøhmer	Lillehammer
Norway	Innlandet Hospital Trust Lillehammer	Lillehammer

Sponsors (1)

Lead Sponsor	Collaborator
Ellen Bøhmer

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of supplementary computer tomography and magnetic resonance imaging of the brain.	Number	3 months
Primary	The number of blood sugar measurements	Number	72 hours after admission to hospital
Secondary	Troponin measurement,	frequency and level of max value	72 hours
Secondary	Number of blood pressure measurement	Number	72 hours
Secondary	Transfer to tertiary center	Number	72 hours